Pfizer Seizes Airspace Fees

Pfizer and BioNTech have found an unusual route to recover unpaid COVID-19 vaccine money: Europe's air-traffic payment system. The companies secured a Belgian court order freezing route charges, the fees airlines pay to cross a country's airspace, before that money reached Poland and Romania. The result is that the air-navigation agencies in Warsaw and Bucharest, which pay the controllers guiding aircraft across their skies, have been cut off from most of their income (Dziennik Gazeta Prawna, Zone Bourse/Reuters). Flights are still moving. The money that keeps the system staffed is not.

How a vaccine bill reaches a radar screen

The enforcement does not target aircraft, towers or equipment. It targets money while it is still in transit. Eurocontrol, the Brussels-based organisation that coordinates European air-traffic management, runs a Central Route Charges Office. It collects airspace fees from airlines and passes each state its share.

Pfizer went through the Belgian courts, obtained an enforceable judgment, meaning a court-backed right to collect the debt, and instructed enforcement officers to seize the money held at Eurocontrol before it could reach Warsaw or Bucharest. For a small EU state like Malta, where air links are not a luxury but part of the country’s economic bloodstream, the mechanism matters as much as the dispute itself: a commercial creditor has found a pressure point inside a European public-service payment system.

The debt goes back to the pandemic. The European Commission negotiated vaccine purchase agreements with manufacturers for the member states, but each government remained the buyer of its allocated doses (European Commission). The BioNTech/Pfizer agreement became the EU’s dominant vaccine contract through the end of 2023, according to the European Court of Auditors. When demand collapsed and some governments refused to pay for doses they no longer wanted, the contracts remained in force. The unused doses became unpaid bills.

Two agencies caught in someone else's fight

Poland's air-navigation agency, PAŻP, said on 1 July that Eurocontrol had notified it that present and future transfers were frozen under Pfizer's enforcement action, even though PAŻP was not party to any vaccine contract (Newsweek Polska). Route charges account for more than 80% of the agency's revenue (Aviation24). The Polish judgment behind the case reportedly comes to about PLN 5.6 billion plus costs (Business Insider Polska, Rzeczpospolita). Infrastructure Minister Dariusz Klimczak estimated that PAŻP may need around PLN 1 billion to keep operating until the end of the year (Do Rzeczy).

Romania's ROMATSA is facing the same squeeze. Finance Minister Alexandru Nazare said the enforcement targets money collected by Eurocontrol on Romania's behalf, rather than ROMATSA's own bank accounts (Lumea Politică). The Romanian judgment is reportedly worth about EUR 600 million for doses ordered but never taken (Jurnalul). ROMATSA has warned that its operating cash could run out within weeks. Both governments are challenging the enforcement in Belgian courts; for now, flights remain normal (Radio Romania International, Radio Cluj).

Why this matters beyond two countries

Pfizer's case is not complicated. The company says the contracts were valid, a court accepted its claim, and it is using normal legal tools to recover what it is owed (Rzeczpospolita). That argument cannot be dismissed. If governments can reserve manufacturing capacity in a crisis and then abandon the bill once the emergency has passed, the next round of emergency procurement will be harder and more expensive.

The collection method is the more troubling part. A debt linked to health procurement is being enforced against the income stream of agencies responsible for air safety. PAŻP and ROMATSA did not sign vaccine contracts. Their staff manage aircraft. Cutting off their funding does not settle the vaccine dispute; it turns a public safety service into leverage against governments.

Eurocontrol's route-charge system works because it is a single European collection point. That efficiency now looks like a vulnerability. Any creditor with an enforceable judgment and identifiable state money passing through Brussels could try the same route against another member state.

The Belgian rulings have not been published in full, so the legal boundary remains unclear. The central question is whether revenue used to fund public safety services should be shielded from commercial debt enforcement. Poland and Romania have not yet tested that argument in court. Until they do, every EU government with unpaid debts has a reason to look more closely at what passes through Brussels before it reaches home.